Search clinical trials for: Gene expression test using nanostring technology.

Total 17 results

Barretos Cancer Hospital

Completed

Identification of Predictive Gene Expression Profile of Sunitinib Response in Metastatic Clear Cell Renal Carcinomas

Kidney Cancer | Biomarkers | Gene Expression

Brazil
Cedar Associates LLC
Pathwork Diagnostics

Terminated

A Prospective Study of Clinical Outcomes for the Pathwork Tissue of Origin Test

Neoplasm Metastasis

United States
Transplant Genomics, Inc.
Scripps Health

Enrolling by invitation

Molecular Biomarkers in Renal Transplantation Via TruGraf® Test

Kidney Transplant Rejection

United States
Inonu University
Anadolu University

Active, not recruiting

Inflammatory and Anti-Inflammatory Gene Expressions in Liver Transplant Patients

Infections | Immune Response | Liver Transplant; Complications | Gene Amplification

Turkey
Mansoura University

Completed

Role of Novel Urinary Genomic and Metablomic Markers in Diagnosis of Bladder Cancer in Patients With Hematuria

Bladder Cancer | Hematuria

Egypt
Transplant Genomics, Inc.
California Pacific Medical Center

Recruiting

Immunosuppression Management in Renal Transplant Recipients With Transplant Excellence Based on TruGraf Test

Kidney Transplant Rejection | Immunosuppression

United States
Brigham and Women's Hospital

Completed

Trial of Dialysate Sodium in Chronic Hospitalized Hemodialysis Patients

Intra-dialytic Hypotension

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Not yet recruiting

Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer

Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage IV Uterine Corpus Cancer | Endometrial Serous Adenocarcinoma

United States
Hospices Civils de Lyon

Completed

Medical Economics of Urinary PCA3 Test for Prostate Cancer Diagnosis

Patients Scheduled for Prostate Biopsy Because of Increased Serum PSA and/or Abnormal Digital Rectal Examination

France
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide

Multiple Myeloma and Plasma Cell Neoplasm
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402

Lymphoma
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lymphoma

Lymphoma
Zagazig University

Completed

Enhanced Recovery After Lumber Laminectomy Using Epidural and General Anesthesia

Endotracheal Tube | Postoperative Recovery | Laminectomy | Epidural Blockade

Egypt
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma

Lymphoma

United States
University Hospital, Toulouse

Recruiting

Neurofeedback-EEG Rehabilitation Protocol on Motor Recovery in the Subacute Phase Post-stroke (CUSTOM-NF-STROKE)

Cerebrovascular Accident

France
Roswell Park Cancer Institute
Ortho Biotech, Inc.

Terminated

Bortezomib, Doxorubicin Hydrochloride Liposome, and Rituximab in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment

Lymphoma

United States
University of Nebraska
National Cancer Institute (NCI); Genta Incorporated

Terminated

Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

Stage III Adult Diffuse Large Cell Lymphoma | Stage IV Adult Diffuse Large Cell Lymphoma | Contiguous Stage II Adult Diffuse Large Cell Lymphoma | Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma | Stage I Adult Diffuse Large Cell Lymphoma

United States

Search clinical trials for: Gene expression test using nanostring technology.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations